Although NK cells and CD8+ T cells have different target recognition mechanisms and signaling activations, both cells can be specialized to use cancer immunotherapy to increase immune‐toxic activity to cancer cells.[29] Therefore, unfolded plasma proteins around NPs could be used for upregulating the levels of immune cells in the tumor microenvironment; thus, the suggested novel strategy can be used along with conventional immunotherapy. Here, CD8A is linked to cancer.